Atlas Trials

Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma

RecordFirmDate
Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma (NCT05202782)Northwestern University2022-03-21
Cardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Standard of Care Chimeric Antigen Receptor T Cell Therapy (NCT04870853)M.D. Anderson Cancer Center2020-04-02

Track Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.